These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2404798)

  • 1. Antithrombin activity of the hirudin N-terminal core domain residues 1-43.
    Chang JY; Schlaeppi JM; Stone SR
    FEBS Lett; 1990 Jan; 260(2):209-12. PubMed ID: 2404798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production, properties, and thrombin inhibitory mechanism of hirudin amino-terminal core fragments.
    Chang JY
    J Biol Chem; 1990 Dec; 265(36):22159-66. PubMed ID: 2266119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the structure of hirudin from Hirudinaria manillensis by limited proteolysis. Isolation, characterization and thrombin-inhibitory properties of N-terminal fragments.
    Vindigni A; De Filippis V; Zanotti G; Visco C; Orsini G; Fontana A
    Eur J Biochem; 1994 Dec; 226(2):323-33. PubMed ID: 8001550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of fragments of hirudin to investigate thrombin-hirudin interaction.
    Dennis S; Wallace A; Hofsteenge J; Stone SR
    Eur J Biochem; 1990 Feb; 188(1):61-6. PubMed ID: 2180697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamic investigation of hirudin binding to the slow and fast forms of thrombin: evidence for folding transitions in the inhibitor and protease coupled to binding.
    Ayala YM; Vindigni A; Nayal M; Spolar RS; Record MT; Di Cera E
    J Mol Biol; 1995 Nov; 253(5):787-98. PubMed ID: 7473752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structural elements of hirudin which bind to the fibrinogen recognition site of thrombin are exclusively located within its acidic C-terminal tail.
    Chang JY; Ngai PK; Rink H; Dennis S; Schlaeppi JM
    FEBS Lett; 1990 Feb; 261(2):287-90. PubMed ID: 2107100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function relationships of the C-terminal functional domain of hirudin and its variants.
    Krstenansky JL; Mao SJ
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):91-6. PubMed ID: 1773003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of recombinant hirudins.
    Stürzebecher J; Walsmann P
    Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of monoclonal antibodies to hirudin and hirudin peptides. A method for studying the hirudin--thrombin interaction.
    Schlaeppi JM; Vekemans S; Rink H; Chang JY
    Eur J Biochem; 1990 Mar; 188(2):463-70. PubMed ID: 1690651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
    Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin inhibition by hirudin: how hirudin inhibits thrombin.
    Fenton JW; Villanueva GB; Ofosu FA; Maraganore JM
    Haemostasis; 1991; 21 Suppl 1():27-31. PubMed ID: 1894193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant hirudin: kinetic mechanism for the inhibition of human thrombin.
    Stone SR; Hofsteenge J
    Protein Eng; 1991 Feb; 4(3):295-300. PubMed ID: 1857714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65).
    Schmitz T; Rothe M; Dodt J
    Eur J Biochem; 1991 Jan; 195(1):251-6. PubMed ID: 1991472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid purification and revised amino-terminal sequence of hirudin: a specific thrombin inhibitor of the bloodsucking leech.
    Mao SJ; Yates MT; Blankenship DT; Cardin AD; Krstenansky JL; Lovenberg W; Jackson RL
    Anal Biochem; 1987 Mar; 161(2):514-8. PubMed ID: 3578808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new class of potent thrombin inhibitors that incorporates a scissile pseudopeptide bond.
    DiMaio J; Ni F; Gibbs B; Konishi Y
    FEBS Lett; 1991 Apr; 282(1):47-52. PubMed ID: 2026264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of in vitro clot growth by r-hirudin is more effective and longer sustained than by an analogous peptide.
    Römisch J; Stöhr HA; Stauss H; Koschinsky R; Stüber W; Pâques EP
    Thromb Haemost; 1994 Mar; 71(3):320-4. PubMed ID: 8029796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I.
    Myles T; Le Bonniec BF; Betz A; Stone SR
    Biochemistry; 2001 Apr; 40(16):4972-9. PubMed ID: 11305913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the hirudin carboxy-terminal peptide 54-65 on the interaction of thrombin with platelets.
    Jandrot-Perrus M; Huisse MG; Krstenansky JL; Bezeaud A; Guillin MC
    Thromb Haemost; 1991 Sep; 66(3):300-5. PubMed ID: 1746000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of thrombin by synthetic hirudin peptides.
    Binnie CG; Erickson BW; Hermans J
    FEBS Lett; 1990 Sep; 270(1-2):85-9. PubMed ID: 2226793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the structural elements of hirudin C-terminal peptide that bind to the fibrinogen recognition site of alpha-thrombin.
    Chang JY
    Biochemistry; 1991 Jul; 30(27):6656-61. PubMed ID: 2065053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.